Medicine
Volume 36, Issue 9 , Pages 467-470 , September 2008

Dementia

References 

  1. Knapp M. Dementia UK: Report to the Alzheimer’s Society. Alzheimer’s Society; 2007;
  2. Hardy J, Higgins GA. Amyloid deposition as the central event in the aetiology of Alzheimer’s Disease. Trends Pharmacol Sci. 1992;12:383–388
  3. Ashe KH. In search of the molecular basis of memory loss in Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20:200–201
  4. Meyer MR, Tschanz JT, Norton MC, et al. APOE genotype predicts when–not whether–one is predisposed to develop Alzheimer disease. Nat Genet. 1998;19:321–322
  5. Kalaria RN, Viitanen M, Kalimo H, Dichgans M, Tabira T. The pathogenesis of CADASIL: an update. J Neurol Sci. 2004;15:35–39
  6. Scarpini E, Galimberti D, Bresolin N. Genetics and neurobiology of frontotemporal lobar degeneration. Neurol Sci. 2006;27(Suppl. 1):S32–S34
  7. Wilhelmsen KC, Lynch T, Pavlou E, Higgins M, Nygaard TG. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet. 1994;55:1159–1165
  8. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920–924
  9. Folstein MF, Folstein SE, McHugh PR. Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198
  10. Roman GC. Vascular dementia. Advances in nosology, diagnosis, treatment and prevention. Panminerva Med. 2004;46:207–215
  11. Geser F, Wenning GK, Poewe W, McKeith I. How to diagnose dementia with Lewy bodies: state of the art. Mov Disord. 2005;20(Suppl. 12):S11–S20
  12. Stewart JT. The frontal/subcortical dementias: common dementing illnesses associated with prominent and disturbing behavioral changes. Geriatrics. 2006;61:23–27
  13. McKeith IG, Burn DJ, Ballard CG, et al. Dementia with Lewy bodies. Sem Clin Neuropsychiatry. 2003;8:46–57
  14. Engelborghs S, Maertens K, Marien P, et al. Behavioural and neuropsychological correlates of frontal lobe features in dementia. Psychol Med. 2006;36:1173–1182
  15. McNeill R, Sare GM, Manoharan M, et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2007;78:350–355
  16. McKeith I, O’Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305–313
  17. National Institute for Health and Clinical Excellence . Donepezil, galantamine, rivastigmine and memantine for Alzheimer’s disease. Technology appraisal guidance 111. London: NICE; 2006;Available at: http://www.nice.org.uk/TA111(accessed 13 June 2008)
  18. Gill SS, Rochon PA, Herrmann N, et al. Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study. BMJ. 2005;330:26

PII: S1357-3039(08)00204-1

doi: 10.1016/j.mpmed.2008.07.006

Medicine
Volume 36, Issue 9 , Pages 467-470 , September 2008

Article Tools

* Image Usage & Resolution